Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

11.6K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.6K
RNA Editing02:23

RNA Editing

9.3K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.3K
CRISPR01:59

CRISPR

53.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.4K
Blood Transfusion01:15

Blood Transfusion

892
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
892

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced γ-globin reactivation and sickle cell correction through a repressor-to-activator motif switch in the <i>HBG1/2</i> promoters.

Molecular therapy. Nucleic acids·2026
Same author

CleanFinder: a scalable framework for comprehensive genome editing analysis.

Trends in biotechnology·2026
Same author

Clinical application of base editing for treating β-thalassaemia.

Nature·2026
Same author

MMS22L is a novel key actor of normal and pathological erythropoiesis.

HemaSphere·2025
Same author

Base editing of β<sup>0</sup>-thalassemia mutations as a therapeutic strategy for severe β-hemoglobinopathies.

Science translational medicine·2025
Same author

Unveiling the cut-and-repair cycle of designer nucleases in human stem and T cells via CLEAR-time dPCR.

Nature communications·2025

Related Experiment Video

Updated: Oct 15, 2025

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.8K

Base and Prime Editing Technologies for Blood Disorders.

Panagiotis Antoniou1, Annarita Miccio1, Mégane Brusson1

  • 1Université de Paris, Imagine Institute, Laboratory of Chromatin and Gene Regulation During Development, INSERM UMR 1163, Paris, France.

Frontiers in Genome Editing
|October 29, 2021
PubMed
Summary

Base editing, a CRISPR-Cas9 technology, offers precise DNA modifications without double-strand breaks, showing promise for treating blood disorders by correcting point mutations efficiently.

Keywords:
CRISPR/Cas9base editingblood diseasesgenetic disordersgenome editing

More Related Videos

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids
07:14

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Published on: May 16, 2025

258
Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

29.0K

Related Experiment Videos

Last Updated: Oct 15, 2025

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.8K
Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids
07:14

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Published on: May 16, 2025

258
Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

29.0K

Area of Science:

  • Molecular Biology
  • Gene Editing Technologies

Background:

  • Nuclease-based genome editing shows potential for blood disorder treatment but carries risks associated with double-strand breaks (DSBs).
  • Base editing, a CRISPR-Cas9 derivative, enables targeted point mutations without inducing DSBs, offering a safer alternative.

Purpose of the Study:

  • To review the development and applications of base editing technology for treating genetic blood disorders.
  • To compare base editing with traditional genome editing strategies and discuss its challenges and advantages.

Main Methods:

  • Review of base editing technologies, including cytidine base editors (CBEs) and adenine base editors (ABEs).
  • Discussion of advancements in base editing efficiency, specificity, accessibility, and multiplexing capabilities.
  • Analysis of challenges such as base editor delivery and off-target effects.

Main Results:

  • Base editing has evolved with expanded scope, higher efficiency, and reduced insertion/deletion (InDel) rates.
  • Base editing is a promising therapeutic strategy for point mutation-caused genetic diseases, particularly blood disorders.
  • Newer base editing systems and prime editing offer expanded capabilities for genetic correction.

Conclusions:

  • Base editing presents a safer and potentially more effective therapeutic strategy for blood disorders compared to DSB-generating methods.
  • Ongoing advancements in base editing and prime editing technologies further enhance their potential for treating genetic diseases.
  • Addressing challenges in delivery and off-target events is crucial for clinical translation of base editing therapies.